Sargent Investment Group, LLC Teva Pharmaceutical Industries LTD Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

A detailed history of Sargent Investment Group, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sargent Investment Group, LLC holds 109,300 shares of TEVA stock, worth $1.91 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

109,300

Previous 122,580 10.83%

Holding current value

$1.91 Million

Previous $1.99 Million 1.1%

% of portfolio

0.36%

Previous 0.41%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$15.81 - $18.96 $209,956 - $251,788	-13,280 Reduced 10.83%	109,300 $1.97 Million
Q2 2024 Aug 09, 2024	SELL	$12.78 - $17.4 $25,560 - $34,800	-2,000 Reduced 1.61%	122,580 $1.99 Million
Q1 2024 May 10, 2024	SELL	$10.67 - $14.43 $26,888 - $36,363	-2,520 Reduced 1.98%	124,580 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $135,201 - $193,402	-18,075 Reduced 12.45%	127,100 $1.3 Million
Q2 2023 Jul 31, 2023	SELL	$7.2 - $9.47 $1.22 Million - $1.61 Million	-169,500 Reduced 53.87%	145,175 $1.09 Million
Q1 2023 May 02, 2023	BUY	$8.36 - $11.37 $50,160 - $68,220	6,000 Added 1.94%	314,675 $2.78 Million
Q4 2022 Jan 31, 2023	BUY	$7.95 - $9.48 $174,900 - $208,560	22,000 Added 7.67%	308,675 $2.82 Million
Q3 2022 Oct 26, 2022	BUY	$6.86 - $11.95 $491,038 - $855,381	71,580 Added 33.28%	286,675 $2.48 Million
Q2 2022 Jul 26, 2022	BUY	$7.38 - $10.4 $1.2 Million - $1.69 Million	162,545 Added 309.31%	215,095 $1.62 Million
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $395,000 - $509,500	50,000 Added 1960.78%	52,550 $421,000
Q2 2021 Aug 05, 2021	BUY	$9.9 - $11.56 $25,245 - $29,478	2,550 New	2,550 $25,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account

Sargent Investment Group, LLC Teva Pharmaceutical Industries LTD Transaction History